methamphetamine has been researched along with am 251 in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nováková, J; Sulcová, A; Vinklerová, J | 1 |
| Landa, L; Slais, K; Sulcova, A | 1 |
| Boctor, SY; France, CP; Koek, W; Martinez, JL | 1 |
| Gilman, JP; Goldberg, SR; Justinova, Z; Makriyannis, A; Panlilio, LV; Schindler, CW; Vemuri, VK | 1 |
| Barrett, DA; Colado, MI; Feng, S; Gutierrez-Lopez, MD; Llopis, N; O'Shea, E | 1 |
| Boctor, SY; Flores, LC; Martinez, JL; Phelix, CF; Rodriguez, JS | 1 |
| Nawata, Y; Yamaguchi, T; Yamamoto, T | 1 |
| Kitaichi, K; Nawata, Y; Yamamoto, T | 1 |
| Dang, DK; Jang, CG; Jeong, JH; Kim, HC; Ledent, C; Mai, AT; Nabeshima, T; Nah, SY; Onaivi, ES; Shin, EJ; Yamamoto, T | 1 |
9 other study(ies) available for methamphetamine and am 251
| Article | Year |
|---|---|
Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251.
Topics: Amphetamine-Related Disorders; Animals; Central Nervous System Stimulants; Conditioning, Operant; Dose-Response Relationship, Drug; Ligands; Male; Methamphetamine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Reinforcement Schedule; Self Administration; Substance Abuse, Intravenous | 2002 |
Impact of cannabinoid receptor ligands on behavioural sensitization to antiaggressive methamphetamine effects in the model of mouse agonistic behaviour.
Topics: Agonistic Behavior; Animals; Arachidonic Acids; Behavior, Animal; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Central Nervous System Stimulants; Drug Administration Schedule; Drug Interactions; Indoles; Ligands; Male; Methamphetamine; Mice; Mice, Inbred ICR; Piperidines; Pyrazoles; Random Allocation; Receptors, Cannabinoid; Statistics, Nonparametric | 2006 |
The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding.
Topics: Animals; Body Temperature; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Dronabinol; Infusions, Intravenous; Injections, Intraperitoneal; Male; Methamphetamine; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Reinforcement Schedule; Self Administration; Time Factors | 2007 |
Effects of cannabinoid receptor antagonists on maintenance and reinstatement of methamphetamine self-administration in rhesus monkeys.
Topics: Animals; Cannabinoid Receptor Antagonists; Conditioning, Operant; Dose-Response Relationship, Drug; Extinction, Psychological; Female; Macaca mulatta; Male; Methamphetamine; Piperidines; Pyrazoles; Reinforcement, Psychology; Rimonabant; Secondary Prevention; Self Administration | 2010 |
Involvement of 2-arachidonoyl glycerol in the increased consumption of and preference for ethanol of mice treated with neurotoxic doses of methamphetamine.
Topics: Alcohol Drinking; Amidohydrolases; Animals; Arachidonic Acids; Central Nervous System Stimulants; Choice Behavior; Dopamine; Dopamine Plasma Membrane Transport Proteins; Endocannabinoids; Glycerides; Limbic System; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Monoacylglycerol Lipases; Neurotoxicity Syndromes; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1 | 2010 |
Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration.
Topics: Animals; Central Nervous System Stimulants; Conditioning, Operant; Drug Interactions; Male; Methamphetamine; Microdialysis; Nucleus Accumbens; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Self Administration | 2011 |
[JSNP Excellent Presentation Award for AsCNP 2011: improvement of cognitive impairments on withdrawal after repeated methamphetamine by administration of a cannabinoid CB1 receptor antagonist and a COX inhibitor].
Topics: Animals; Awards and Prizes; Cognition Disorders; Cyclooxygenase Inhibitors; Diclofenac; Male; Methamphetamine; Mice; Mice, Inbred ICR; Mice, Knockout; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Substance Withdrawal Syndrome | 2012 |
Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.
Topics: Amphetamine-Related Disorders; Animals; Cannabinoid Receptor Antagonists; Cues; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Pyrazoles; Rats; Self Administration | 2016 |
Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice.
Topics: Animals; Apoptosis; Butadienes; Cells, Cultured; Corpus Striatum; Dopamine; Extracellular Signal-Regulated MAP Kinases; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurotoxicity Syndromes; Nitriles; Oxidative Stress; Piperidines; Protein Kinase C-delta; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; Rimonabant; Sulpiride | 2017 |